Erik Thunnissen

Erik Thunnissen

UNVERIFIED PROFILE

Are you Erik Thunnissen?   Register this Author

Register author
Erik Thunnissen

Erik Thunnissen

Publications by authors named "Erik Thunnissen"

Are you Erik Thunnissen?   Register this Author

100Publications

3148Reads

38Profile Views

Correlation of ROS1 Immunohistochemistry With Fusion Status Determined by Fluorescence In Situ Hybridization.

Arch Pathol Lab Med 2019 Sep 11. Epub 2019 Sep 11.

From Roche Molecular Solutions, Pleasanton, California (Dr Huang, Mr Smith, Dr Le, Mr Liu, Dr Ordinario, Dr Manohar, Mr Lee, Mr Rajamani, Mr Truong, Dr Jing Li, Ms Choi, Dr Jingchuan Li, Dr Pati, Ms Hanlon Newell, Mr Pate, and Dr Menzl); Institute of Pathology, University Hospital Basel, Basel, Switzerland (Dr Bubendorf); Institute for Pathology, University Hospital, Cologne, Germany (Dr Buettner); the Department of Pathology, Aberdeen University Medical School & Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom (Dr Kerr); Laboratorio de Dianas Terapeuticas, HM Hospitales, Spain (Dr Lopez-Rios); Center of Predictive Molecular Medicine, CeSIMeT, University of Chieti-Pescara, Italy (Dr Marchetti); Pfizer Oncology, International Developed Markets, Berlin, Germany (Ms Marondel); the Department of Histopathology, Royal Brompton and Harefield Hospitals, and National Heart and Lung Division, Imperial College, London, United Kingdom (Dr Nicholson); the Pathology Department, Istanbul University, Cerrahpassa Medical Faculty, Istanbul, Turkey (Dr Öz); CORE, Antwerp University, and the Department of Pathology, Antwerp University Hospital, Antwerp, Belgium (Mr Pauwels); the Department of Biopathology, Centre Jean Perrin & INSERM U240 IMoST and Université Clermont Auvergne, Clermont-Ferrand, France (Dr Penault-Llorca); Operative Unit of Pathology, AUSL della Romagna, Hospital S. Maria delle Croci, Ravenna, Italy (Dr Rossi); and the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2019-0085-OADOI Listing
September 2019

In Reply.

Authors:
Erik Thunnissen

Arch Pathol Lab Med 2019 Aug;143(8):909-910

Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2019-0198-LEDOI Listing
August 2019

PD-L1 Antibody Comparison in Urothelial Carcinoma.

Eur Urol 2019 03 27;75(3):538-540. Epub 2018 Nov 27.

Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.11.002DOI Listing
March 2019

Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.

J Proteomics 2019 Mar 30;196:106-119. Epub 2019 Jan 30.

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2019.01.018DOI Listing
March 2019

How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer.

Authors:
Erik Thunnissen

Arch Pathol Lab Med 2019 Jan 11;143(1):11-12. Epub 2018 Oct 11.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-041
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0410-EDDOI Listing
January 2019

Gross handling of pulmonary resection specimen: maintaining the 3-dimensional orientation.

J Thorac Dis 2019 Jan;11(Suppl 1):S37-S44

Department of Pathology Amsterdam University Medical Centers, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.12.36DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353737PMC
January 2019

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.

J Thorac Oncol 2018 09 12;13(9):1410-1414. Epub 2018 Jul 12.

University of Groningen, University Medical Center Groningen, Center for Medical Imaging - North East Netherlands, Groningen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.006DOI Listing
September 2018

Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review.

Lung Cancer 2018 09 18;123:107-111. Epub 2018 Jul 18.

Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.07.017DOI Listing
September 2018

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLC.

J Thorac Oncol 2018 08 24;13(8):1222-1226. Epub 2018 Apr 24.

Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.012DOI Listing
August 2018

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.

Br J Cancer 2018 08 31;119(5):558-564. Epub 2018 Jul 31.

Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0194-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162232PMC
August 2018

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.

Clin Cancer Res 2018 01 24;24(1):33-42. Epub 2017 Oct 24.

Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1921DOI Listing
January 2018

PD-L1 IHC in NSCLC with a global and methodological perspective.

Lung Cancer 2017 11 18;113:102-105. Epub 2017 Sep 18.

Department of Thoracic Oncology, Netherlands Cancer Institute, Plesmanlaan 121 1066 CX, Amsterdam, the Netherlands; Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.09.010DOI Listing
November 2017

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.

Eur Respir J 2017 10 26;50(4). Epub 2017 Oct 26.

Dept of Pulmonary Diseases, GROW school for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01658-2017DOI Listing
October 2017

A Prospective Study of Loose Tissue Fragments in Non-Small Cell Lung Cancer Resection Specimens: An Alternative View to "Spread Through Air Spaces".

Am J Surg Pathol 2017 Sep;41(9):1226-1230

*Department of Pathology, OLVG §Department of Pathology, Netherlands Cancer Institute Departments of ∥Epidemiology and Biostatistics ¶Pathology, VU University Medical Center, Amsterdam, The Netherlands †Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA ‡Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000889DOI Listing
September 2017

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Eur Respir J 2017 06 1;49(6). Epub 2017 Jun 1.

Dept of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01838-2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898951PMC
June 2017

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.

J Thorac Oncol 2016 12 25;11(12):2241-2247. Epub 2016 Jul 25.

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.012DOI Listing
December 2016

A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors.

J Thorac Oncol 2016 Apr 9;11(4):593-602. Epub 2016 Jan 9.

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.106DOI Listing
April 2016

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.

J Thorac Oncol 2016 Mar 24;11(3):e35-8. Epub 2015 Dec 24.

Department of Respiratory Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.013DOI Listing
March 2016

Ex Vivo Artifacts and Histopathologic Pitfalls in the Lung.

Arch Pathol Lab Med 2016 Mar;140(3):212-20

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen, de Cuba, and Yick);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0292-OADOI Listing
March 2016

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Eur Respir J 2016 Feb 5;47(2):615-24. Epub 2015 Nov 5.

Dept of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00618-2015DOI Listing
February 2016

Diagnostic challenges in survivors of early stage lung cancer.

Lung Cancer 2015 Nov 24;90(2):212-6. Epub 2015 Aug 24.

Department of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.08.013DOI Listing
November 2015

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Lung Cancer 2015 Sep 6;89(3):255-61. Epub 2015 Jun 6.

Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.023DOI Listing
September 2015

Comprehensive genomic profiles of small cell lung cancer.

Nature 2015 Aug 13;524(7563):47-53. Epub 2015 Jul 13.

1] Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, 50931 Cologne, Germany. [2] Department of Pathology, University Hospital Cologne, 50937 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861069PMC
August 2015

Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?

Lung Cancer 2015 Jul 20;89(1):19-26. Epub 2015 Apr 20.

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.04.005DOI Listing
July 2015

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.

J Clin Pathol 2015 Apr 6;68(4):320-1. Epub 2015 Feb 6.

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands Department of Pulmonary Diseases, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2015-202866DOI Listing
April 2015

Granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung.

Med Oral Patol Oral Cir Bucal 2015 Jan 1;20(1):e30-3. Epub 2015 Jan 1.

VU university medical center, Dept. of Oral and Maxillofacial Surgery/Oral Pathology, P.O.Box 7057, 1007MB, Amsterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320418PMC
http://dx.doi.org/10.4317/medoral.19867DOI Listing
January 2015

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

J Clin Oncol 2014 Sep 28;32(25):2780-7. Epub 2014 Jul 28.

Fiona H. Blackhall and Daisuke Nonaka, Manchester University and The Christie National Health Services Foundation Trust, Manchester; Keith M. Kerr, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; Solange Peters and Igor Letovanec, Centre Hospitalier Universitaire Vaudois, Lausanne; Lukas Bubendorf and Spasenija Savic, Institute for Pathology, University Hospital Basel, Basel; Alex Soltermann and Rolf A. Stahel, University Hospital Zurich, Zurich, Switzerland; Urania Dafni, Frontier Science Foundation-Hellas and University of Athens, Athens, Greece; Henrik Hager, University Hospital, Aarhus, Denmark; Kenneth J. O'Byrne, St James's Hospital, Dublin, Ireland; Christoph Dooms, University Hospital KU Leuven, Leuven, Belgium; Aleksandra Sejda, Medical University of Gdansk, Gdansk, Poland; Javier Hernández-Losa, Vall d'Hebron University Hospital, Barcelona; Miguel Martorell, Universitat de Valencia and Hospital General Universitario de Valencia, Valencia; Rafael Rosell, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain; Antonio Marchetti, Center of Predictive Molecular Medicine, University Foundation, Chieti, Italy; Qiang Tan, Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; Erik Thunnissen, VU University Medical Clinic Center; Jeroen de Jong, Netherlands Cancer Institute, Amsterdam; Ernst-Jan M. Speel, Maastricht University Medical Centre, Maastricht, the Netherlands; and Richard Cheney, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.5921DOI Listing
September 2014

Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.

J Thorac Oncol 2014 Sep;9(9):1354-62

Departments of *Pathology and ††††Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands; †Department of Pathology, Faculty of Medicine, Tsukuba, Japan; ‡Rutgers New Jersey Medical School, Newark, New Jersey; §Department of Pathology, Mount Sinai Medical Center, New York, New York; ‖Elisabeth Brambilla, CHU Albert Michallon, Institut de Biologie, Département d'Anatomie et Cytologie Pathologiques, Grenoble Cedex, France; ¶Brigham and Women's Hospital, Boston, Massachusetts; #Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; **Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; ††Piedmont Pathology Associates, Hickory, North Carolina, and University of North Carolina, Chapel Hill, North Carolina; ‡‡Department of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado; §§Division of Pathology, The Cancer Institute, Japanese Foundation Cancer Research, Tokyo, Japan; ‖Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; ¶¶Department of Pathology, CHU A Michallon, INSERM U 823-Institut A Bonniot-University J Fourier, Grenoble, France; ##Department of Pathology, Cancer Center Hospital, Tsukuba, Japan; ***Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan; †††Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; ‡‡‡Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, and Università degli Studi of Milan, Milan, Italy; §§§Institut für Pathologie, Jena, Germany; ‖‖‖Duke University Medical Center, Durham, North Carolina; ¶¶¶University of Texas MD Anderson Cancer Center, Houston, Texas; ###Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan; ****Department of Oncology and Radiothe

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000264DOI Listing
September 2014

How reliable are clinical criteria in distinguishing between Birt-Hogg-Dubé syndrome and smoking as a cause for pneumothorax?

Histopathology 2014 Jun 8;64(7):1045-6. Epub 2014 Mar 8.

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12362DOI Listing
June 2014

Methylation analysis in spontaneous sputum for lung cancer diagnosis.

Lung Cancer 2014 May 31;84(2):127-33. Epub 2014 Jan 31.

Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.01.019DOI Listing
May 2014

Prognostic and predictive biomarkers in lung cancer. A review.

Virchows Arch 2014 Mar 14;464(3):347-58. Epub 2014 Jan 14.

Departments of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-014-1535-4DOI Listing
March 2014

In compressed lung tissue microscopic sections of adenocarcinoma in situ may mimic papillary adenocarcinoma.

Arch Pathol Lab Med 2013 Dec;137(12):1792-7

From the Departments of Pathology (Drs Thunnissen and Beliën), Radiology (Dr Lely), and Surgery (Dr Hartemink), VU University Medical Center, Amsterdam, the Netherlands; the Department of Pathology, Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, Scotland (Dr Kerr); the Department of Pathology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea (Dr Chung); the Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania (Dr Flieder); the Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan (Dr Noguchi); the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe); the Department of Pathology, University Health Network-Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada (Drs Hwang and Tsao); and the Department of Pathology, Symbiant/Medical Center Alkmaar, Alkmaar, the Netherlands (Dr Meijer-Jorna).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0613-SADOI Listing
December 2013

A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation.

Clin Cancer Res 2013 Feb 6;19(3):743-51. Epub 2012 Dec 6.

Department of Pulmonary Diseases and GROW- School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1779DOI Listing
February 2013

Pulmonary adenocarcinoma histology.

Authors:
Erik Thunnissen

Transl Lung Cancer Res 2012 Dec;1(4):276-9

VU University Medical Center, Dept. Pathology, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2012.10.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367552PMC
December 2012

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Nat Genet 2012 Oct 2;44(10):1104-10. Epub 2012 Sep 2.

Department of Translational Genomics, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2396DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915822PMC
October 2012

An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?

J Thorac Oncol 2012 Aug;7(8):e3-5

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31825bceadDOI Listing
August 2012